Both in Pharmaceuticals
Nkarta vs Minerva Neurosciences
Over the past year NKTX returned −12.2% and NERV returned −30.0%; their daily moves had a correlation of 0.21.
NKTX −12.2% NERV −30.0%Growth of $1, one year, split-adjusted
| Metric | NKTX | NERV |
|---|---|---|
| Price | $1.73 | $2.57 |
| Market cap | $123.9M | $122.7M |
| Today | +13.07% | +9.36% |
| 1 month | −25.1% | −25.1% |
| 6 months | −47.9% | −58.7% |
| Year to date | −6.5% | −36.1% |
| 1 year | −16.4% | −32.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $182.8M | $75.3M |
| Dividend yield | — | — |
| Volatility (60d) | 65.9% | 79.8% |
| Short % of float | 8.1% | 6.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).